Shell Asset Management’s Sage Therapeutics SAGE Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-7,405	Closed	-$282K	–	1316
2022 Q4	$282K	Sell	7,405 -1,556	-17%	-$59.4K	0.01%	810
2022 Q3	$351K	Sell	8,961 -2,348	-21%	-$90.8K	0.01%	752
2022 Q2	$365K	Buy	11,309 +18	+0.2%	+$603	0.01%	884
2022 Q1	$374K	Sell	11,291 -1,672	-13%	-$62.9K	0.01%	950
2021 Q4	$551K	Buy	12,963 +2,712	+26%	+$114K	0.01%	858
2021 Q3	$454K	Sell	10,251 -440	-4%	-$20.2K	0.01%	915
2021 Q2	$607K	Buy	10,691 +580	+6%	+$41K	0.01%	825
2021 Q1	$757K	Buy	10,111 +5,723	+130%	+$469K	0.02%	654
2020 Q4	$380K	Hold	4,388	–	–	0.01%	908
2020 Q3	$268K	Hold	4,388	–	–	0.01%	950
2020 Q2	$182K	Sell	4,388 -85	-2%	-$3.08K	﹤0.01%	1044
2020 Q1	$128K	Sell	4,473 -70	-2%	-$4.05K	﹤0.01%	1087
2019 Q4	$328K	Sell	4,543 -132	-3%	-$16.2K	0.01%	1034
2019 Q3	$656K	Sell	4,675 -40	-0.8%	-$6.69K	0.02%	749
2019 Q2	$863K	Sell	4,715 -109	-2%	-$18.6K	0.02%	628
2019 Q1	$767K	Buy	4,824 +2,404	+99%	+$348K	0.02%	705
2018 Q4	$232K	Sell	2,420 -200	-8%	-$22.9K	0.01%	1020
2018 Q3	$370K	Hold	2,620	–	–	0.01%	1034
2018 Q2	$410K	Sell	2,620 -100	-4%	-$15.7K	0.01%	977
2018 Q1	$438K	Buy	+2,720	New	+$462K	0.01%	946